Tackling COVID-19
As we stay apart, pharmaceutical companies are coming together to fight against COVID-19
LEARN MOREIntellectual Property
Europe’s framework of incentives and rewards for discovering and developing new treatments deliver access to today’s medicines and investment into tomorrow’s cures for patients who need them.
LEARN MORE
Help us make rare disease even rarer
Only 8 OMP medicines existed in 2000, before the EU Regulation came in to force, compared to 184 today.
LEARN MORE
Relationships and Code
EFPIA Code of Practice and relationships with patient organisations and healthcare professionals
LEARN MORE
Latest Updates
VIEW ALL-
Blog articles 25.02.21
From diagnosis to awareness
Innovation has to be about patients, and everyone who lives with a disease, however common or rare, deserves the chance for a normal life.
Read Article -
Blog articles 25.02.21
New Normal, Same Cancer (Guest blog)
Strong coordinated efforts are needed to reduce the future impacts of the pandemic on cancer patients
Read Article -
Blog articles 24.02.21
#WeWontRest until we make treatments for rare disease less rare
Some diseases are rare. Treating them shouldn't be.
Read Article -
External Events 15.03.21
DIA Europe 2021
Dedicated to Advancing Healthcare Priorities
View Event -
External Events 18.03.21
Decentralised Patient-Centric Trials: From Theory to Practice
Are remote trials the future? Take a deep dive into patient-centric decentralised trial conduct and explore how these trials and modern technology offer...
View Event -
External Events 15.04.21
Innovation for Health
On 15-16 April 2021, the 8th edition of Innovation for Health takes place as a hybrid edition.
View Event
Featured Articles
